Tympanogen
About:
Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.
Website: http://www.tympanogen.com
Top Investors: Virginia Venture Partners, MassChallenge, ShockVentures, NO/LA Angel Network, Virginia Catalyst
Description:
Tympanogen develops novel materials to improve treatment outcomes and decrease healthcare costs for otolaryngologists and their patients. Its flagship product, Perf-Fix, is the first gel patch for nonsurgical eardrum repair.
Total Funding Amount:
$3.29M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Richmond, Virginia, United States
Founded Date:
2014-01-01
Founders:
Elaine Horn-Ranney, Jesse Ranney, Parastoo Khoshakhlagh
Number of Employees:
1-10
Last Funding Date:
2022-04-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai